Thus, we speculate that stimulating PPAR-γ signaling or enhancing carnitine homeostasis may have therapeutic benefits in conditions of endothelial dysfunction such as pulmonary hypertension, diabetes, and atherosclerosis. Here, PPARG is linked to endothelial dysfunction.